Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
ADP-ribosylation factors (ARFs) play an important role in intracellular vesicular trafficking.
Showing 10 out of 26 products:
Human Polyclonal ARFGEF2 Primary Antibody for IF, ELISA - ABIN1534705
Deloukas, Matthews, Ashurst, Burton, Gilbert, Jones, Stavrides, Almeida, Babbage, Bagguley, Bailey, Barlow, Bates, Beard, Beare, Beasley, Bird, Blakey, Bridgeman, Brown, Buck, Burrill, Butler, Carder et al.: The DNA sequence and comparative analysis of human chromosome 20. ... in Nature 2002
Human Polyclonal ARFGEF2 Primary Antibody for ICC, IF - ABIN4281377
Christis, Munro: The small G protein Arl1 directs the trans-Golgi-specific targeting of the Arf1 exchange factors BIG1 and BIG2. in The Journal of cell biology 2012
coordinated interactions between actin (through FlnA (show FLNA Antibodies)) and vesicle trafficking (through Big2-Arf (show CDKN2A Antibodies)) direct the assembly and disassembly of membrane protein complexes required for neuronal migration and neuroependymal integrity.
an early acting GEF (show ARHGEF2 Antibodies) (GBF1 (show PTGES2 Antibodies)) activates ARFs that mediate recruitment of late acting GEFs (BIG1 (show CNTN3 Antibodies)/2) to coordinate coating events within the pre-Golgi/Golgi/TGN (show TG Antibodies) continuum.
Big2 inhibition promotes Filamin A (show FLNA Antibodies) phosphorylation, thereby disrupting cell intrinsic neuronal migration.
Results indicate that murine BIG2 is essential for early embryonic development.
Description of a novel ARFGEF2 mutation in five related patients presenting with West syndrome, microcephaly, periventricular heterotopia and thin corpus callosum.
The clinical phenotype associated with mutations in ARFGEF2 is relatively homogeneous in the families report.
Arf guanine nucleotide-exchange factors BIG1 and BIG2 regulate nonmuscle myosin IIA activity by anchoring myosin phosphatase complex.
an early acting GEF (show SLC2A4RG Antibodies) (GBF1 (show GBF1 Antibodies)) activates ARFs that mediate recruitment of late acting GEFs (BIG1 (show CNTN3 Antibodies)/2) to coordinate coating events within the pre-Golgi/Golgi/TGN (show TG Antibodies) continuum.
Brefeldin A-inhibited ADP-ribosylation factor activator BIG2 regulates cell migration via integrin beta1 cycling and actin remodeling.
Up-regulation of ARFGEF2 is associated with the Huntington's disease.
BIG1 (show CNTN3 Antibodies) and BIG2 have roles in endomembrane organization
BIG2 and Exo70 (show EXOC7 Antibodies) interact in trans-Golgi network and centrosomes, as well as in exocyst structures or complexes that move along microtubules to the plasma membrane.
ARFGEF2 mRNA was widely expressed in all cortical layers, especially in the neural precursors of the ventricular and subventricular zones during development, with persistent but diminished expression in adulthood.
Regulates the constitutive release of tumor necrosis factor receptor type 1 (show TNFRSF1A Antibodies) exosome-like vesicles from vascular endothelial cells.
ADP-ribosylation factors (ARFs) play an important role in intracellular vesicular trafficking. The protein encoded by this gene is involved in the activation of ARFs by accelerating replacement of bound GDP with GTP and is involved in Golgi transport. It contains a Sec7 domain, which may be responsible for its guanine-nucleotide exchange activity and also brefeldin A inhibition.
ADP-ribosylation factor guanine nucleotide-exchange factor 2 (brefeldin A-inhibited)
, cytohesin 1-like
, brefeldin A-inhibited GEP 2
, brefeldin A-inhibited guanine nucleotide-exchange protein 2
, Brefeldin A-inhibited guanine nucleotide-exchange factor 2